Log in
A+ A A-

Eating chocolate cuts risk of heart disease

Eating high levels of chocolate could be associated with a significant reduction in the risk of certain cardiovascular disorders, reveals Cambridge research published in the British Medical Journal this week.

 

The researchers compiled a systematic review of seven studies using data from 114,000 patients and found that people who consumed the most chocolate had a 37 per cent lower risk of developing heart disease and a 29 per cent lower risk of suffering a stroke than those who consumed less chocolate.

The studies looked at the consumption of dark chocolate as well as milk chocolate, chocolate drinks and other chocolate confectionaries.

Although the analysis suggests a certain benefit to eating higher quantities of chocolate, the findings still need to be interpreted with caution, in particular because commercially available chocolate is very calorific and eating too much of it could in itself lead to weight gain, which increases various health risks.

(0 votes)

Hemodynamic Results After Transcatheter Aortic Valve Implantation (TAVI): Up to 3 Years Follow-up of 338 Patients After CoreValve Implantation

Topics: Valvular Heart Diseases

 

Since 2007 Transcatheter Aortic Valve Implantation (TAVI) has become an alternative treatment for elderly patients with severe aortic stenosis at high risk for surgical aortic valve replacement.

At present, durability and hemodynamic performance of transcatheter aortic valves remain unclear. Our single center data of the German Heart Center in Munich demonstrates a sustained improvement of hemodynamic performance up to 3 years after CoreValve implantation.

(0 votes)

Intra-aortic Balloon Pumps Do Not Reduce Infarct Size in Patients with STEMI without Cardiac Shock: the CRISP AMI trial

Hot Line III - Acute Coronary Syndromes Topics: Acute Coronary Syndromes (ACS)

 

Intra-aortic balloon pump counterpulsation prior to PCI in patients with ST segment elevation MI does not reduce infarct size as measured by MRI, according to results from the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction (CRISP AMI) trial.

Intra-aortic balloon counterpulsation is a procedure in which a balloon inserted in the aorta is timed to inflate at the start of diastole and to deflate before the start of systole. This increases diastolic pressure, which increases coronary perfusion and oxygen delivery to the myocardium, and facilitates ejection of blood from the left ventricle. There is evidence that LV unloading before reperfusion can reduce the extent of the infarct; infarct size has been shown to predict LV function after AMI.

(0 votes)
Subscribe to this RSS feed

39°F

New York

Fair

Humidity: 20%

Wind: 7 mph

  • 5 Apr 2016 43°F 29°F
  • 6 Apr 2016 49°F 44°F